EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 35 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 2.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $650,000 | -49.1% | 637,696 | -22.6% | 0.13% | -15.9% |
| Q4 2019 | $1,278,000 | -10.1% | 824,310 | +4.9% | 0.16% | -23.4% |
| Q3 2019 | $1,422,000 | -0.9% | 785,645 | -10.2% | 0.20% | +4.1% |
| Q2 2019 | $1,435,000 | +45.8% | 875,098 | +59.2% | 0.20% | +35.9% |
| Q1 2019 | $984,000 | -54.2% | 549,750 | -51.6% | 0.14% | -14.2% |
| Q4 2018 | $2,148,000 | +347.5% | 1,136,282 | +744.8% | 0.17% | +201.8% |
| Q3 2018 | $480,000 | +182.4% | 134,509 | +65.0% | 0.06% | +166.7% |
| Q2 2018 | $170,000 | – | 81,532 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 41,909,219 | $68,731,000 | 39.63% |
| CVI Holdings, LLC | 1,367,430 | $2,244,000 | 0.87% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 875,098 | $1,435,000 | 0.20% |
| BARD ASSOCIATES INC | 87,884 | $144,000 | 0.07% |
| HIGHLAND CAPITAL MANAGEMENT LP | 545,000 | $894,000 | 0.05% |
| HighTower Advisors, LLC | 5,284,738 | $8,667,000 | 0.05% |
| Kore Private Wealth LLC | 104,366 | $171,000 | 0.04% |
| Arcus Capital Partners, LLC | 25,000 | $41,000 | 0.02% |
| MOORE CAPITAL MANAGEMENT, LP | 320,000 | $525,000 | 0.01% |
| MATRIX ASSET ADVISORS INC/NY | 26,500 | $43,000 | 0.01% |